Log In
Print
BCIQ
Print
Print this Print this
 

Oral CR845 (CR845)

  Manage Alerts
Collapse Summary General Information
Company Cara Therapeutics Inc.
DescriptionLong-acting peripheral kappa opioid receptor (KOR) agonist
Molecular Target Kappa opioid receptor (OPRK1) (KOR)
Mechanism of ActionKappa opioid receptor agonist
Latest Stage of DevelopmentPhase II
IndicationPain
Partner

Chong Kun Dang Pharmaceutical Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today